Financials Neochim AD

Equities

NEOH

BG11NEDIAT11

Agricultural Chemicals

End-of-day quote Bulgaria S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
19.5 BGN +8.33% Intraday chart for Neochim AD +8.33% -20.41%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 142.2 83.79 44.22 67.24 58.44 105.5
Enterprise Value (EV) 1 125.3 101.9 62.98 55.01 -10.38 3.66
P/E ratio 12.2 x -4.22 x -3.57 x 4.5 x 1.25 x 1.51 x
Yield - - - 1.54% 22.1% 12.3%
Capitalization / Revenue 0.62 x 0.38 x 0.17 x 0.3 x 0.17 x 0.17 x
EV / Revenue 0.55 x 0.46 x 0.25 x 0.25 x -0.03 x 0.01 x
EV / EBITDA 4.53 x -11.2 x -53.5 x 1.99 x -0.16 x 0.04 x
EV / FCF -15.4 x -4.24 x 12.7 x 2.17 x -0.24 x 0.15 x
FCF Yield -6.48% -23.6% 7.88% 46.1% -413% 667%
Price to Book 1.28 x 0.91 x 0.55 x 0.7 x 0.41 x 0.53 x
Nbr of stocks (in thousands) 2,586 2,586 2,586 2,586 2,586 2,586
Reference price 2 55.00 32.40 17.10 26.00 22.60 40.80
Announcement Date 4/12/18 4/10/19 2/27/20 2/25/21 4/29/22 4/26/23
1BGN in Million2BGN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 228.8 221.6 256.6 221.4 352.2 629.5
EBITDA 1 27.63 -9.059 -1.177 27.63 63.64 88.47
EBIT 1 16.18 -20.44 -12.01 17.17 53.36 78.55
Operating Margin 7.07% -9.23% -4.68% 7.75% 15.15% 12.48%
Earnings before Tax (EBT) 1 13.33 -20.99 -13.54 15.13 51.62 77.92
Net income 1 11.7 -19.87 -12.4 14.94 46.65 70.04
Net margin 5.11% -8.96% -4.83% 6.75% 13.25% 11.13%
EPS 2 4.524 -7.683 -4.795 5.777 18.04 27.09
Free Cash Flow 1 -8.124 -24.03 4.963 25.35 42.87 24.42
FCF margin -3.55% -10.84% 1.93% 11.45% 12.17% 3.88%
FCF Conversion (EBITDA) - - - 91.76% 67.36% 27.61%
FCF Conversion (Net income) - - - 169.72% 91.89% 34.87%
Dividend per Share - - - 0.4000 5.000 5.000
Announcement Date 4/12/18 4/10/19 2/27/20 2/25/21 4/29/22 4/26/23
1BGN in Million2BGN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 18.1 18.8 - - -
Net Cash position 1 16.9 - - 12.2 68.8 102
Leverage (Debt/EBITDA) - -1.996 x -15.94 x - - -
Free Cash Flow 1 -8.12 -24 4.96 25.4 42.9 24.4
ROE (net income / shareholders' equity) 11% -19.5% -14.4% 17% 39.4% 41%
ROA (Net income/ Total Assets) 6.23% -8.92% -5.71% 8.62% 22.2% 24.5%
Assets 1 187.9 222.6 217.3 173.2 210.2 286
Book Value Per Share 2 43.10 35.60 30.90 36.90 54.90 77.20
Cash Flow per Share 2 10.40 0.3900 1.010 7.070 27.90 39.60
Capex 1 5.08 6.5 4.16 4.14 3.1 2.51
Capex / Sales 2.22% 2.93% 1.62% 1.87% 0.88% 0.4%
Announcement Date 4/12/18 4/10/19 2/27/20 2/25/21 4/29/22 4/26/23
1BGN in Million2BGN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
19.5
Average target price
-
Consensus

Annual profits - Rate of surprise